[Role of disorders of cyclic adenosine-3',5'--monophosphate (cAMP) in the pathogenesis of bronchial asthma].
D000818:Animals; D001249:Asthma / Q000188:drug therapy / Q000378:metabolism*; D001427:Bacterial Toxins / Q000276:immunology; D001792:Blood Platelets / Q000378:metabolism; D001886:Bordetella pertussis; D002395:Catecholamines / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D004195:Disease Models, Animal; D006633:Histamine Antagonists / Q000627:therapeutic use; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D006967:Hypersensitivity / Q000378:metabolism; D007962:Leukocytes / Q000187:drug effects; D008213:Lymphocyte Activation; D008247:Lysosomes / Q000378:metabolism; D010974:Platelet Aggregation; D011453:Prostaglandins / Q000494:pharmacology; D011943:Receptors, Adrenergic, beta
D001427:Bacterial Toxins; D002395:Catecholamines; D006633:Histamine Antagonists; D011453:Prostaglandins; D011943:Receptors, Adrenergic, beta; D000242:Cyclic AMP
Znachenie narusheniĭ metabolizma tsiklicheskogo adenozin--3',5'-monofosfata (tsAMF) v patogeneze bronkhial'noĭ astmy